Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A historical essay on detection of anti-neutrophil cytoplasmic antibodies.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2015
Same author

International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies.

Annals of the rheumatic diseases·2013
Same author

Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor.

Clinical and experimental rheumatology·2013
Same author

Relations of serum COMP to cardiovascular risk factors and endothelial function in patients with rheumatoid arthritis treated with methotrexate and TNF-α inhibitors.

The Journal of rheumatology·2012
Same author

Preliminary evaluation of the first international reference preparation for anticitrullinated peptide antibodies.

Annals of the rheumatic diseases·2012
Same author

EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis.

Annals of the rheumatic diseases·2010

Related Experiment Video

Updated: Jul 7, 2026

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

Drug-induced vasculitis.

Allan Wiik1

  • 1Department of Autoimmunology, Statens Serum Institut, Copenhagen, Denmark. asw@dadlnet.dk

Current Opinion in Rheumatology
|February 19, 2008
PubMed
Summary
This summary is machine-generated.

Drug-induced vasculitis and lupus-like disease can mimic idiopathic autoimmune conditions. Unique autoantibody profiles, including antineutrophil cytoplasm antibodies, aid in distinguishing drug-induced syndromes from idiopathic ones.

Related Experiment Videos

Last Updated: Jul 7, 2026

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

Area of Science:

  • Rheumatology
  • Immunology
  • Pharmacology

Background:

  • Drug-induced vasculitis and lupus-like disease present diagnostic challenges, mimicking idiopathic autoimmune syndromes like primary vasculitides and systemic lupus erythematosus.
  • Numerous drugs across various pharmacologic classes have been implicated in inducing these conditions, leading to diverse clinical presentations from single-organ involvement to severe systemic disease.
  • Distinguishing these drug-induced conditions from their idiopathic counterparts is crucial for appropriate patient management and treatment.

Purpose of the Study:

  • To highlight key features differentiating drug-induced vasculitis and lupus-like disease from idiopathic autoimmune syndromes.
  • To review the diagnostic utility of specific autoantibodies in identifying drug-induced conditions.
  • To emphasize the role of laboratory marker profiles in differential diagnostics.

Main Methods:

  • Review of recent literature on drug-induced vasculitis and drug-induced lupus-like disease.
  • Analysis of serological findings, particularly antineutrophil cytoplasm antibodies (ANCA) and other autoantibodies.
  • Focus on diagnostic criteria and biomarkers for differentiating drug-induced from idiopathic autoimmune syndromes.

Main Results:

  • Recent findings show ANCA positivity in a significant subset of drug-induced vasculitis/lupus-like disease, particularly those linked to antithyroid drug treatment.
  • A unique serological profile characterized by ANCA with specificity to multiple lysosomal antigens, alongside antibodies to histones and beta-2 glycoprotein 1, is identified.
  • This specific autoantibody profile aids in the differential diagnosis of drug-induced vasculitis/lupus-like disease.

Conclusions:

  • The rational application of specific laboratory marker profiles, including ANCA and other autoantibodies, is essential for distinguishing drug-induced from idiopathic autoimmune syndromes.
  • These autoantibodies serve as valuable biomarkers for various phenotypes of drug-induced vasculitis and drug-induced lupus-like disease.
  • Further research into autoantibody profiles can refine diagnostic strategies for these drug-induced conditions.